Re The Wellcome Foundation Ltd
Read the full judgment text of HCMP 2102/1988 on BabelCite. This High Court CFI judgment.
1. This is an appeal from a decision of Miss A.C. Waters acting for the Registrar General as Registrar of Trade Marks, (the Registrar) dated the 22nd July 1988, although the beening was held on the 10th December 1985, allowing the registration by Otsuka Pharmaceutical Co. Ltd. (the respondent) of the mark "Meptin" in Class 5 of Schedule IV in respect of pharmaceutical drugs and medicines in Part A of the Register. The registration is opposed by the Wellcome Foundation Limited (the appellant) who
Cited by 7 cases
|
HCMP002102/1988 1988 M.P. No. 2102 ______________ H E A D N O T E ______________ This was an appeal against a decision of the Registrar of Trade Marks, allowing the registration of a trademark "Meptin" relating to a pharmaceutical product. The appellant, who was the proprietor of the trademark "Septrin" another pharmaceutical product used for the same purpose opposed the registration on the grounds that the phonetic resemblance of the two words was likely to deceive or confuse the majority of the purchasing public. HELD:- 1. The respondent had to establish that there could be no likelihood of deception or confusion arising between the two words, either visually or phonetically.
Obiter : the policy of the Trade Marks Ordinance is to allow legitimate traders to have their honest trademarks registered. 1988 M.P. No. 2102 IN THE SUPREME COURT OF HONG KONG HIGH COURT ------------
Coram: Hon. Jones J. in Court Dates of hearing: 4th - 6th January 1989 Date of handing down judgment: 17th January 1989 --------------------- J U D G M E N T --------------------- 1. This is an appeal from a decision of Miss A.C. Waters acting for the Registrar General as Registrar of Trade Marks, (the Registrar) dated the 22nd July 1988, although the beening was held on the 10th December 1985, allowing the registration by Otsuka Pharmaceutical Co. Ltd. (the respondent) of the mark "Meptin" in Class 5 of Schedule IV in respect of pharmaceutical drugs and medicines in Part A of the Register. The registration is opposed by the Wellcome Foundation Limited (the appellant) who are the registered proprietors of the mark "Septrin" in Class 5 of Schedule IV in respect of all goods included in such class. 2. The appellant is a large pharmaceutical company in England which has factories in other parts of the world. The mark "Septrin" is used for pharmaceutical and medical preparations and substances including products for the use in the treatment of bacterial infections of the respiratory tracts. "Meptin" is also used in respect of pharmaceutical preparations for the same purpose. 3. Septrin has been registered in the United Kingdom as a trade mark since December 1947 and appears to have been first used there in about 1968. The mark has also been registered in a number of other countries in the world and was registered in Hong Kong in 1969. However, Septrin has not been registered in Japan. The first user in Hong Kong was in 1971. From an annual turnover of $282,232.06 for the year 1971/72, sales increased to $739,499.00 in 1981/82, at the time when the respondent made the application to register the mark "Meptin". 4. The respondent is a pharmaceutical company in Japan where the mark "Meptin" was registered in 1978. The mark has also been registered in a number of other countries including some countries where the appellant has registered "Septrin". 5. The respondent applied for the registration of "Meptin" in Hong Kong in 1979 and have used the goods in Hong Kong since 1981. 6. The appellant opposes the registration of the mark under sections 12(1), 20 and 23 of the Trade Marks Ordinance and I will now set out the provisions of those sections.
7. Mr Thomas, Q.C., who appeared for the appellant, submitted the following questions for consideration under section 12 and section 20. The first question under section 12 reads "Having regard to the reputation or the use of the mark 'Septrin' in Hong Kong by the appellant, is the court satisfied that 'Meptin' if used in a normal and fair manner in connection with any goods covered by the proposed registration will be unlikely to cause deception amongst a substantial number of persons?". The second question under section 20 "Assuming the use of the mark 'Septrin' in Hong Kong in a normal and fair manner for any of the goods covered by the registration (and including particularly goods covered by the proposed registration), is the court satisfied that there will be no reasonable likelihood of deception or confusion among a substantial number of persons if 'Meptin' is used normally and fairly in respect of any goods covered by the proposed registration. Both these questions are derived from similar questions that were formulated in Smith Hayden & Co. Ltd (1946)63 R.P.C. 97 see the judgment of Evershed J. at 101. Mr Rogers, Q.C., counsel for the respondent formulated one question that covered the position under section 20 in practically the same terms. 8. The burden lies upon the respondent to establish to the satisfaction of the court that there is no likelihood likelihood of deception or confusion. Mr Thomas conceded that if he fails under sections 12 and 20, he cannot succeed under section 23. 9. In order to determine the issue of resemblance as likely to deceive, the Registrar's attention was drawn to the test set out by Parker J. in the Pianotist Company Ltd (1906)23 R.P.C. 774 where at 777 he said :-
10. The hearing of this appeal is by way of rehearing so that it is my duty to consider the case afresh, although having regard to the wide experience of the Registrar, great weight should be given to her decision, which should not be lightly disturbed see F. Reddaway & Co. Ltd. [1927]44 R.P.C. 27. 11. In considering the persons who are likely to be deceived and the nature of the goods, the Registrar considered the possibility of confusion and considered that the evidence of user by the respondent after the date of the application could be taken into account. She decided that upon the evidence, the products could be sold over the counter to members of the public and did not require a doctor's prescription. 12. Mr Thomas did not seek to argue the question of visual resemblance for it is clear that there could be no deception or confusion arising from the get-up of the two products which are clearly distinguishable. The argument has therefore concentrated upon the phonetic resemblance of the two words on the basis that "Meptin" so closely resembles "Septrin" as to be likely to deceive or confuse those seeking pharmaceutical treatment for respiratory infections. In particular, I was urged to take into consideration the fact that the majority of members of the purchasing public in Hong Kong are likely to be Chinese, many of whom do not read or understand English. In comparing the two marks, the Registrar, in her decision at page 15, analysed the two words as follows :-
13. Mr Thomas, levelled criticism at the Registrar's decision when she said that "the marks do have similarities but I have to consider the sounds of the two marks MEPTIN and SEPTRIN when compared as a whole and I find that there is a difference and that the phonetic resemblance is slight." Mr Thomas disagreed with that view contending that the sounds of the two words are strikingly similar and rhyme whilst the "R" would be slurred. 14. There was no admissible evidence before the court of either deception or confusion with the result that it is for the court to decide whether one mark so nearly resembles the other as to be likely to deceive or to cause confusion. 15. The task of the Court is to look at the two words as a whole and not to compare them syllable by syllable see William Bailey (Birmingham) Ltd (1935)52 R.P.C. 136. In considering this matter, I have taken into account imperfect recollection and enunciation which is not clear and to orders being made over the telephone and over the counter, which matters were taken into consideration by the Registrar together with the fact that the local population is 98% Chinese. My views on these points coincide with those of the Registrar. The Registrar also properly disregarded the question of concurrent registration which was not an issue upon the appeal. There is a marked difference between the pronunciation of the first syllable of the two words which, in my judgment, could not conceivably cause any confusion. Further, I agree with the decision of the Registrar that the "R" in "Septrin" would not be slurred. As has been said in the authorities see Aristoc Ltd v Rysta Ltd (1945)62 R.P.C. 65 and Smith Hayden & Co. Ltd, the issue is one of first impression and my first impression was that there could be no likelihood of confusion arising between the two words, either visually or phonetically. The sound of the first syllable of the two words is quite distinct. In the circumstances, I have no hesitation in coming to the conclusion that the Registrar was entirely correct in the decision that she made. The onus of proof has therefore been discharged by the respondent. Further, there was no evidence that the respondent had any knowledge of Septrin before the application was made to register Meptin or that there was any improper motive in making the application. 16. There remains one submission raised by Mr Thomas upon which I should comment which concerns the policy of the Trade Marks Ordinance. He argued that the policy is to ensure fair competition and to decide the boundaries of unfair competition so that newcomers to the trade should be discouraged from sailing close to the wind. However, I am unable to agree that this is the policy that underlies the ordinance, but that it is to allow as submitted by Mr Rogers legitimate traders to have their honest trade marks registered. 17. In the result, the appeal will be dismissed with costs.
Representation: Mr M.D. Thomas, Q.C. and Mr P. Garland (Baker & McKenzie) for Appellant. Mr A. G. Rogers, Q.C. and Miss P. Wong (Johnson, Stokes & Master) for Respondent. |
Other judgments that cite this case